Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Novartis

    Tag: novartis

    You Searched For "Novartis"
    Gilead licenses respiratory, herpes antiviral research programs from Novartis

    Gilead licenses respiratory, herpes antiviral research programs from Novartis

    Medical Dialogues Bureau23 July 2019 9:15 AM IST
    Under the agreement, Gilead will acquire exclusive global rights to develop and commercialize novel small molecules against three undisclosed targets....
    Novartis CEO sets aside 700 Million Dollar to settle doctor bribery lawsuit

    Novartis CEO sets aside 700 Million Dollar to settle doctor bribery lawsuit

    Medical Dialogues Bureau20 July 2019 9:52 AM IST
    ZURICH: Novartis Chief Executive Vas Narasimhan set aside $700 million to settle a U.S. doctor bribery lawsuit, as the Swiss drugmaker seeks to close...
    Novartis sickle cell drug crizanlizumab secures speedy USFDA review

    Novartis sickle cell drug crizanlizumab secures speedy USFDA review

    Medical Dialogues Bureau17 July 2019 9:26 AM IST
    Novartis submitted the application for crizanlizumab for the prevention of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD) and...
    CDSCO Committee turns down Novartis FDC drug including Vildagliptin, Metformin, Glimepiride

    CDSCO Committee turns down Novartis FDC drug including Vildagliptin, Metformin, Glimepiride

    Farhat Nasim11 July 2019 5:38 PM IST
    New Delhi: The Swiss drugmaker, Novartis recently presented before the Central Drugs Standard Control Organization(CDSCO) Technical Committee to seek...
    Lupin unveils generic Imatinib Mesylate tablets to treat types of cancer

    Lupin unveils generic Imatinib Mesylate tablets to treat types of cancer

    Medical Dialogues Bureau10 July 2019 10:00 AM IST
    Lupin's Imatinib Mesylate Tablets, 100mg (base) and 400mg (base), is the generic version of Novartis Pharmaceuticals Corporation's (Novartis) Gleevec...
    Novartis introduces 26 week gender-neutral parental leave for birth, adoption, surrogacy

    Novartis introduces 26 week gender-neutral parental leave for birth, adoption, surrogacy

    Farhat Nasim2 July 2019 12:55 PM IST
    The new parental leave policy is effective July 1, 2019 and applies to birthing and non-birthing parents in the case of birth, adoption and surrogacy,...
    Sandoz, Kit Check collaborate to track, automate restocking of products in hospitals

    Sandoz, Kit Check collaborate to track, automate restocking of products in hospitals

    Farhat Nasim30 Jun 2019 9:12 AM IST
    By collaborating with Kit Check, Sandoz will be able to better understand how its medicines are used in hospitals, optimize the supply chain by...
    GSK offers concessions to address Pfizer deal concerns

    GSK offers concessions to address Pfizer deal concerns

    Farhat Nasim23 Jun 2019 8:59 AM IST
    GSK announced the deal in December last year, a move which will put it ahead of rivals Johnson & Johnson, Bayer and Sanofi.BRUSSELS:...
    Novartis India appoints Sanjay Murdeshwar as Vice Chairman, Managing Director

    Novartis India appoints Sanjay Murdeshwar as Vice Chairman, Managing Director

    Farhat Nasim16 Jun 2019 9:31 AM IST
    Sanjay Murdeshwar is Country President, Novartis in India and responsible for the company's pharmaceuticals business in the country.New Delhi: Pharma...
    Novartis

    Novartis' secret settlement talks revealed in accidental filing: Bloomberg Report

    Medical Dialogues Bureau13 Jun 2019 10:03 AM IST
    The U.S. sued the Novartis six years ago, joining in a case filed by a former sales representative who accused the company of using its speaker's...
    Novartis gets new pharma chief Marie-France Tschudin; bids farewell to Paul Hudson

    Novartis gets new pharma chief Marie-France Tschudin; bids farewell to Paul Hudson

    Farhat Nasim9 Jun 2019 9:25 AM IST
    Marie-France Tschudin succeeds Paul Hudson who will be leaving Novartis to take the CEO position of a multinational pharmaceuticals company.Basel:...
    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    Farhat Nasim4 Jun 2019 5:44 PM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok